|
Q1 2021
Filed on May 14, 2021
|
8,830,000
|
N/A
|
|
|
Q1 2021
Filed on May 14, 2021
|
53,365
|
N/A
|
|
|
Q1 2021
Filed on May 14, 2021
|
2,973,000
|
N/A
|
|
|
Q1 2021
Filed on May 14, 2021
|
175,000
|
$29.02 - $38.97
$5.08M - $6.82M
|
|
|
Q1 2021
Filed on May 14, 2021
|
11,050,000
|
N/A
|
|
|
Q1 2021
Filed on May 14, 2021
|
7,636,000
|
N/A
|
|
|
Q1 2021
Filed on May 14, 2021
|
80,000
|
$16.43 - $23.83
$1.31M - $1.91M
|
|
|
Q1 2021
Filed on May 14, 2021
|
22,877
|
$596.5 - $654.65
$13.6M - $15M
|
|
Marvell Technology Group LTD
|
Q1 2021
Filed on May 14, 2021
|
75,000
|
N/A
|
|
|
Q1 2021
Filed on May 14, 2021
|
521,142
|
$9.97 - $14.34
$5.2M - $7.47M
|
|
|
Q1 2021
Filed on May 14, 2021
|
1,370,706
|
$15.31 - $17.02
$21M - $23.3M
|
|
|
Q1 2021
Filed on May 14, 2021
|
8,941,000
|
N/A
|
|
|
Q1 2021
Filed on May 14, 2021
|
195,447
|
$42.36 - $58.58
$8.28M - $11.4M
|
|
Western Asset Mtg Cap Corp
|
Q1 2021
Filed on May 14, 2021
|
6,700,000
|
N/A
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
35,000
|
$3.16 - $4.76
$111K - $167K
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
894,955
|
N/A
|
|
Teva Pharmaceutical Fin LLC
|
Q4 2020
Filed on Feb 16, 2021
|
14,620,000
|
N/A
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
411,600
|
$74.87 - $89.65
$30.8M - $36.9M
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
2,363,380
|
N/A
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
750,656
|
N/A
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
82,600
|
$15.66 - $34.7
$1.29M - $2.87M
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
384,096
|
N/A
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
15,169
|
$73.85 - $120.02
$1.12M - $1.82M
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
75,000
|
$29.35 - $41.24
$2.2M - $3.09M
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
204,000
|
$73.99 - $82.81
$15.1M - $16.9M
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
148,668
|
$7.06 - $13.48
$1.05M - $2M
|
|
Momenta Pharmaceuticals Inc
|
Q4 2020
Filed on Feb 16, 2021
|
60,000
|
N/A
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
400,000
|
N/A
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
45,000
|
N/A
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
56,354
|
N/A
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
302,500
|
$21.03 - $28.85
$6.36M - $8.73M
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
23,657
|
$56.16 - $107.49
$1.33M - $2.54M
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
1,341,666
|
$5.56 - $6.61
$7.46M - $8.87M
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
125,000
|
N/A
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
57,155
|
N/A
|
|
Xeris Pharmaceuticals Inc
|
Q4 2020
Filed on Feb 16, 2021
|
6,986,000
|
N/A
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
100,000
|
$12.72 - $16.94
$1.27M - $1.69M
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
150,000
|
N/A
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
94,787
|
$41.13 - $61.66
$3.9M - $5.84M
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
51,877
|
N/A
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
1,149,085
|
$9.17 - $12.64
$10.5M - $14.5M
|
|
Xeris Pharmaceuticals Inc
|
Q4 2020
Filed on Feb 16, 2021
|
4,248
|
N/A
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
20,000
|
N/A
|
|
Portola Pharmaceuticals Inc
|
Q3 2020
Filed on Nov 13, 2020
|
535,000
|
N/A
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
217,276
|
$98.85 - $114.18
$21.5M - $24.8M
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
54,500
|
$34.54 - $36.7
$1.88M - $2M
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
20,600
|
$110.21 - $159.36
$2.27M - $3.28M
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
27,801
|
$229.36 - $272.52
$6.38M - $7.58M
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
100,000
|
$49.12 - $64.83
$4.91M - $6.48M
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
7,979
|
$9.57 - $27.05
$76.4K - $216K
|
|